<DOC>
	<DOCNO>NCT02135315</DOCNO>
	<brief_summary>The intensive arterial pressure control acute coronary syndrome ( ACS ) first 24 hour improve prognosis short long term . We confront two treatment strategy ( standard intensive treatment ) evaluate superiority treatment acute coronary syndrome .</brief_summary>
	<brief_title>Intensive Arterial Pressure Control Acute Coronary Syndrome</brief_title>
	<detailed_description>Acute coronary syndrome often associate arterial pressure elevation deleterious heart need urgent intervention lower blood pressure require value , however clear recommendation concern treatment intensity situation . The investigator know high arterial pressure increase oxygen myocardial consumption deleterious acute coronary syndrome , , logical reduce intensively pressure .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Isosorbide-5-mononitrate</mesh_term>
	<mesh_term>Isosorbide Dinitrate</mesh_term>
	<mesh_term>Isosorbide</mesh_term>
	<mesh_term>Labetalol</mesh_term>
	<criteria>Acute Coronary Syndrome SBP 100 mmHg hemodynamic instability complicate ACS ( arrythmias , atrioventricular block , shock , tamponade ... ) ST elevation myocardial infarction ( STEMI ) contre indication beta blocker ( asthma , chronic obstructive pulmonary disease ( COPD ) , glaucoma , prostatic disorder ... )</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Acute Coronary Syndrome , arterial pressure</keyword>
</DOC>